ISPOR - PCN36 COST IMPLICATIONS OF RESTRICTING PALONOSETRON UTILIZATION FOR THE TREATMENT OF CINV- RESULTS FROM AN ANALYTIC MODEL FROM A PAYER PERSPECTIVE

Full Text

PCN36 COST IMPLICATIONS OF RESTRICTING PALONOSETRON UTILIZATION FOR THE TREATMENT OF CINV- RESULTS FROM AN ANALYTIC MODEL FROM A PAYER PERSPECTIVE

Abstract

Authors

A Powers E Sarnes RL Knoth S Balu D Buchner

Back to Volume 13, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now